• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一般人群肾脏风险评分的制定和验证。

Development and validation of a general population renal risk score.

机构信息

Division of Nephrology, Department of Medicine, University Medical Center Groningen, University Hospital Groningen, Groningen, The Netherlands.

出版信息

Clin J Am Soc Nephrol. 2011 Jul;6(7):1731-8. doi: 10.2215/CJN.08590910.

DOI:10.2215/CJN.08590910
PMID:21734089
Abstract

BACKGROUND AND OBJECTIVES

There is a need for prediction scores that identify individuals at increased risk for developing progressive chronic kidney disease (CKD). Therefore, this study was performed to develop and validate a "renal risk score" for the general population. Design, setting, participants, & measurements For this study we used data from the PREVEND (Prevention of Renal and Vascular ENdstage Disease) study, a prospective population-based cohort study with a median follow-up of 6.4 years. Participants with two or three consecutive estimated GFR (eGFR) measurements during follow-up were included. Participants within the group who had the most renal function decline (top 20% of the total population) and had an eGFR value <60 ml/min per 1.73 m² during follow-up were defined as having progressive CKD. Possible predictors for progressive CKD were selected on the basis of univariable logistic regression analyses.

RESULTS

A final prediction model was built using backward logistic regression analysis. Besides baseline eGFR, the model contained age, urinary albumin excretion, systolic BP, C-reactive protein, and known hypertension. The area under the receiver operating characteristic (ROC) curve was 0.84. We performed internal validation by using a bootstrapping procedure. As expected, after the regression coefficients were corrected for optimism, the area under the ROC curve was still 0.84. For clinical use we divided all predictors in meaningful clinical categories to develop a score chart. The area under the ROC curve was 0.83, indicating the high discriminative value of this model.

CONCLUSIONS

Given the high internal validity of this renal risk score, this score can be helpful to identify individuals at increased risk for progressive CKD.

摘要

背景和目的

需要有一种预测评分系统,用于识别发生进展性慢性肾脏病(CKD)风险增加的个体。因此,本研究旨在开发和验证一种针对普通人群的“肾脏风险评分”。

设计、地点、参与者和测量:本研究使用了 PREVEND(预防肾脏和血管终末期疾病)研究的数据,这是一项前瞻性的基于人群的队列研究,中位随访时间为 6.4 年。纳入了在随访期间有两次或三次连续估算肾小球滤过率(eGFR)测量值的参与者。在该组中,肾功能下降最多(总人群的前 20%)且在随访期间 eGFR 值<60 ml/min/1.73 m²的参与者被定义为发生进展性 CKD。基于单变量逻辑回归分析选择了可能预测进展性 CKD 的预测因素。

结果

使用向后逻辑回归分析构建了最终的预测模型。除了基线 eGFR,该模型还包含年龄、尿白蛋白排泄、收缩压、C 反应蛋白和已知的高血压。接收者操作特征(ROC)曲线下面积为 0.84。我们通过使用自举程序进行了内部验证。正如预期的那样,在对回归系数进行校正以消除乐观偏差后,ROC 曲线下面积仍为 0.84。为了临床应用,我们将所有预测因素划分为有意义的临床类别,以开发评分图表。ROC 曲线下面积为 0.83,表明该模型具有较高的区分能力。

结论

鉴于该肾脏风险评分具有较高的内部有效性,该评分可有助于识别进展性 CKD 风险增加的个体。

相似文献

1
Development and validation of a general population renal risk score.一般人群肾脏风险评分的制定和验证。
Clin J Am Soc Nephrol. 2011 Jul;6(7):1731-8. doi: 10.2215/CJN.08590910.
2
Changes in renal risk factors versus renal function outcome during follow-up in a population-based cohort study.在一项基于人群的队列研究中,随访期间肾风险因素与肾功能结局的变化。
Nephrol Dial Transplant. 2010 Jun;25(6):1846-53. doi: 10.1093/ndt/gfp729. Epub 2010 Jan 6.
3
Prospective study of progression of kidney dysfunction in community-dwelling older adults.社区居住老年人肾功能不全进展的前瞻性研究。
Nephrology (Carlton). 2008 Apr;13(2):99-103. doi: 10.1111/j.1440-1797.2008.00919.x.
4
Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.肾病科转诊前后肾功能的下降及其对中重度慢性肾脏病患者生存的影响。
Nephrol Dial Transplant. 2006 Aug;21(8):2133-43. doi: 10.1093/ndt/gfl198. Epub 2006 Apr 27.
5
Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study.日本普通人群肾小球滤过率下降较慢:一项为期10年的纵向随访研究。
Hypertens Res. 2008 Mar;31(3):433-41. doi: 10.1291/hypres.31.433.
6
Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.血清脂联素与慢性肾脏病和肾移植中的心血管风险。
J Nephrol. 2010 Jan-Feb;23(1):77-84.
7
Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.韩国无高血压或糖尿病男性中代谢综合征与慢性肾脏病风险的时间依赖性关联
Am J Kidney Dis. 2009 Jan;53(1):59-69. doi: 10.1053/j.ajkd.2008.07.027. Epub 2008 Oct 5.
8
Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.比较使用 CKD-EPI 和 MDRD 研究 GFR 估算方程的 CKD 患病率和死亡率风险:AusDiab(澳大利亚糖尿病、肥胖和生活方式)研究。
Am J Kidney Dis. 2010 Apr;55(4):660-70. doi: 10.1053/j.ajkd.2009.12.011.
9
Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening.在人群筛查中,与低估算肾小球滤过率(GFR)相比,大量白蛋白尿是识别有GFR加速下降风险个体的更好风险标志物。
J Am Soc Nephrol. 2006 Sep;17(9):2582-90. doi: 10.1681/ASN.2005121352. Epub 2006 Aug 9.
10
Risk of CKD in Australian indigenous and nonindigenous children: a population-based cohort study.澳大利亚原住民和非原住民儿童患慢性肾脏病的风险:一项基于人群的队列研究。
Am J Kidney Dis. 2009 Feb;53(2):229-37. doi: 10.1053/j.ajkd.2008.08.004. Epub 2008 Oct 18.

引用本文的文献

1
Development and Validation of Survival Scores and the Assessment of Spatial Trends in End-Stage Kidney Disease Outcomes.终末期肾病结局的生存评分的开发与验证及空间趋势评估
Res Sq. 2025 May 27:rs.3.rs-6523746. doi: 10.21203/rs.3.rs-6523746/v1.
2
Approaches to predict future type 2 diabetes mellitus and chronic kidney disease: A scoping review.预测未来2型糖尿病和慢性肾脏病的方法:一项范围综述
PLoS One. 2025 Jun 11;20(6):e0325182. doi: 10.1371/journal.pone.0325182. eCollection 2025.
3
Predicting chronic kidney disease progression with artificial intelligence.
利用人工智能预测慢性肾病进展
BMC Nephrol. 2024 Apr 26;25(1):148. doi: 10.1186/s12882-024-03545-7.
4
Prognostic Models in Nephrology: Where Do We Stand and Where Do We Go from Here? Mapping Out the Evidence in a Scoping Review.肾脏病预后模型:我们处于何处,以及我们从何处出发?在范围综述中描绘证据。
J Am Soc Nephrol. 2024 Mar 1;35(3):367-380. doi: 10.1681/ASN.0000000000000285. Epub 2023 Dec 12.
5
Prediction of incident chronic kidney disease in a population with normal renal function and normo-proteinuria.预测肾功能正常和蛋白尿正常人群中的慢性肾脏病事件。
PLoS One. 2023 May 3;18(5):e0285102. doi: 10.1371/journal.pone.0285102. eCollection 2023.
6
Risk Prediction Score for Chronic Kidney Disease in Healthy Adults and Adults With Type 2 Diabetes: Systematic Review.健康成年人和 2 型糖尿病患者慢性肾脏病风险预测评分的系统评价。
Prev Chronic Dis. 2023 Apr 20;20:E30. doi: 10.5888/pcd20.220380.
7
A nomogram for predicting the 4-year risk of chronic kidney disease among Chinese elderly adults.一种用于预测中国老年人群慢性肾脏病4年发病风险的列线图。
Int Urol Nephrol. 2023 Jun;55(6):1609-1617. doi: 10.1007/s11255-023-03470-y. Epub 2023 Jan 31.
8
Genotype, Proteinuria, and the Risk of Kidney Failure: A Secondary Analysis of the AASK (African American Study of Kidney Disease and Hypertension) and CRIC (Chronic Renal Insufficiency Cohort) Studies.基因型、蛋白尿与肾衰竭风险:非裔美国人肾脏疾病与高血压研究(AASK)及慢性肾功能不全队列研究(CRIC)的二次分析
Kidney Med. 2022 Nov 1;4(12):100563. doi: 10.1016/j.xkme.2022.100563. eCollection 2022 Dec.
9
Prediction models used in the progression of chronic kidney disease: A scoping review.用于慢性肾脏病进展的预测模型:范围综述。
PLoS One. 2022 Jul 26;17(7):e0271619. doi: 10.1371/journal.pone.0271619. eCollection 2022.
10
Translational research in nephrology: prognosis.肾脏病学中的转化研究:预后
Clin Kidney J. 2021 Aug 26;15(2):205-212. doi: 10.1093/ckj/sfab157. eCollection 2022 Feb.